Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease
Tissue Engineering Part C: Methods · 2023
DOI: 10.1089/ten.tec.2022.0200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part C: Methods, 2023. Verfasst von Masatoshi Oka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell Sheet Tissue Engineering Center (CSTEC), University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Sheet Tissue Engineering Center (CSTEC), University of Utah, Salt Lake City, Utah, USA.
- Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah, USA.
- Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
- SCM Lifescience Co., Ltd., Republic of Korea.
- Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Sumako Kameishi
Zitieren
APA
Oka, M., Kameishi, S., Cho, Y. K., Song, S. U., Grainger, D. W., & Okano, T. (2023). Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease. Tissue Engineering Part C: Methods. https://doi.org/10.1089/ten.tec.2022.0200
Vancouver
Oka M, Kameishi S, Cho YK, Song SU, Grainger DW, Okano T. Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease. Tissue Engineering Part C: Methods. 2023. doi:10.1089/ten.tec.2022.0200
BibTeX
@article{Oka2023,
author = {Oka, Masatoshi and Kameishi, Sumako and Cho, Yun-Kyoung and Song, Sun U and Grainger, David W and Okano, Teruo},
title = {Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease},
journal = {Tissue Engineering Part C: Methods},
year = {2023},
doi = {10.1089/ten.tec.2022.0200}
}
EUVIMED